Following the most recent tariff warnings, the Nifty pharma index dropped by 0.9%, with 15 out of 20 companies experiencing ...
Investing in the Nifty 50 ETF offers a low-cost, risk-free way to replicate the performance of 50 major companies across 15 sectors. The ETF provides high liquidity, affordability, and periodic ...
Despite a recent correction in the broader markets, valuations of mid and small-cap stocks remain expensive compared to ...
So, it is predominantly retail that has been selling and that is where the maximum interest was and that is the reason we ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results